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and translation of various RNAs, and may operate as
a multifunctional regulator of tissue-specific gene
expression.
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One of a molecular biologist’s dreams is to explain complex
processes like cell differentiation and development by
simple molecular operations, such as the expression of a
few master regulatory genes. One instance in which the
dream has come true involves the Drosophila RNA-binding
protein Sex-lethal, which brings about changes in pre-
mRNA splicing and mRNA translation of target genes that
orchestrate all aspects of female sexual determination.
Recent reports suggest that the poly-pyrimidine-tract-
binding protein (PTB) also has multiple functions in post-
transcriptional regulation. We shall review this evidence
and discuss the prospects for PTB as a multifunctional
regulator of cell differentiation in mammals.
PTB was first purified as a polypeptide that binds to the
polypyrimidine tract that typically precedes the 3′ splice
sites of higher eukaryotic mRNA introns [1]. Mutations in
the pyrimidine-rich tract were found to have similar effects
on PTB binding and on the assembly of splicing complexes,
so it was proposed that PTB promotes early steps of the
RNA splicing reaction. This view was challenged when
PTB was identified as hnRNP I [2], a member of a family of
proteins that bind to nascent RNAs and play multiple roles
in the nuclear life of transcripts, but that seem to dissociate
from the pre-mRNA when splicing complexes assemble [3].
A first hint about the function of PTB came from studies on
the alternative splicing of tropomyosin pre-mRNAs. In this
process, the same pre-mRNA can follow alternative matura-
tion pathways to generate mRNAs with different coding
capacities. One of the alternative splicing events affecting
both α- and β-tropomyosin pre-mRNAs is a tissue-specific
choice between two exons that are mutually exclusive
(Figure 1). Exon 2 of α-tropomyosin is used only in smooth
muscle, and exon 7 of β-tropomyosin is used only in skele-
tal muscle, thus generating different protein isoforms which
contribute to the distinct mechanical properties of each
type of muscle cell. Several cis-acting sequences were found
to be important for correct tissue-specific alternative splic-
ing of these pre-mRNAs [4–7], and PTB was found to bind
at least some of them [5,6]. In one of these studies [5], it
was proposed that PTB recognizes specific pyrimidine-rich
sequences, and that PTB binding to its cognate sites results
in repression of nearby splice sites.
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Figure 1
Proposed activities of PTB in the alternative
splicing of α- and β-tropomyosin pre-mRNAs.
The relevant exons and introns and splicing
pathways, as well as PTB-binding sites
predicted by two different studies [8,9] are
schematically represented. The arrows point
to the splicing events proposed to be
regulated by PTB. 1 2 3 4
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If this model were correct, the identification of PTB-
binding sites in pre-mRNAs would also serve to identify
target genes and their mode of regulation by PTB. As
usual in these days of in vitro genetics, iterative selection
from random pools of RNA was used to investigate the
precise binding specificity of PTB [8,9]. Related, but dis-
tinct, consensus sequences were obtained, depending on
the detailed conditions of the selection procedure, the
simplest high-affinity binding sites being represented by
the sequence UCUU(C) — and possibly also UUCU/C —
in a pyrimidine-rich context [9,10]. Sequences matching
the various consensus sequences occur in the introns adja-
cent to regulated exons of a variety of genes, and others
are likely to be found in the near future. Below we discuss
the functional evidence that PTB regulates these genes.
In the case of tropomyosins (Figure 1), mutation of the
PTB-binding sites disrupts regulation in vivo [9], and
placing these sequences close to splice sites confers PTB-
mediated splice-site repression in vitro [8,11]. Taken
together, these data indicate that repression of nearby exons
induced by PTB binding results in inclusion of a smooth-
muscle-specific exon in α-tropomyosin mRNAs and skip-
ping of a skeletal-muscle-specific exon in β-tropomyosin
mRNAs, thus allowing the coordinated expression of
protein isoforms in a particular cell type.
Recent reports implicate PTB in coordinating another set of
tissue-specific splicing decisions: the inhibition of neuron-
specific processing patterns in non-neural cells. The pre-
mRNAs of c-src and the GABAA receptor γ2 subunit gene
contain exons which are included in the mature mRNA only
in neurons, and sequences resembling PTB consensus sites
are present within previously described cis-acting regulatory
signals located in the flanking introns [10,12] (Figure 2).
Although these exons are quite small, their presence signifi-
cantly affects the amino-acid sequence of key domains of
the encoded proteins, indicating that regulation of exon
inclusion has important functional consequences. 
Evidence for a regulatory role of PTB came from in vitro
studies using nuclear extracts from HeLa cells, in which
the use of the neuron-specific splice sites is repressed.
Addition of short RNAs corresponding to PTB-binding
sites to these extracts allowed neuron-specific splicing,
presumably by titrating PTB and thus relieving its repres-
sive activity. Two additional observations are consistent
with this interpretation. First, the extent to which splicing
was activated correlated with the affinity of the interaction
between different RNAs and PTB. Second, addition of
purified PTB restored repression [10,12]. 
Taken together, these results support a role for PTB in
preventing neuron-specific splicing events. It should be
noted, however, that more definitive depletion/reconstitu-
tion experiments have not been possible with the reagents
available, and therefore it cannot be formally excluded
that the effects are mediated by binding factors other than
PTB. It is also unclear why addition of purified PTB from
HeLa cells does not repress splicing of c-src pre-mRNA in
nuclear extracts derived from a neuronal cell line [12]. In
this regard, it is important to consider that PTB acts in
concert with other signals and factors that affect regula-
tion, both positively and negatively, most likely reflecting
the need for versatile fine tuning of splice-site usage in
different cells at distinct times during development.
How is splicing inhibited by the presence of PTB? Some
PTB-binding sites are within the polypyrimidine tract
recognized by the splicing factor U2AF [5,6,8,9,12]. Other
sites overlap with the binding site for U2 snRNP [10] or
with enhancer regulatory sequences [10,12]. A simple
model for regulation is that PTB sterically interferes with
the binding of splicing factors that recognize these or
nearby sequences, and indeed PTB has been shown to
compete with the binding of U2AF to some polypyrimi-
dine tracts [8,11]. The more distant location of other PTB
sites from splice signals [7,10,12], together with the obser-
vation that PTB bound to a 3′ splice-site region can inhibit
the use of the 5′ splice site across the exon [5,10,12], sug-
gests that more complex mechanisms of regulation by
PTB are also likely to operate.
A third example of neural-specific processing patterns
modulated by PTB involves the gene that encodes both
the hormone calcitonin and the neuropeptide CGRP
(Figure 2). In thyroid C cells and — if ectopically
expressed — most other tissues, calcitonin mRNA is gen-
erated by inclusion of exon 4 and cleavage/polyadenyla-
tion of the transcript at the end of this exon. In neurons,
however, exon 4 is skipped — and the associated
polyadenylation site ignored — so that the alternative
CGRP mRNA is made. A complex enhancer sequence
present in the downstream intron is important for exon 4
inclusion [13]. The enhancer sequence is composed of a
pyrimidine-rich stretch followed by a 5′ splice site that
binds splicing factors. 
Consensus sequences for PTB were found within the
pyrimidine-rich stretch of the calcitonin/CGRP pre-
mRNA, and competition experiments, similar to those
described above for c-src and the γ2 GABAA receptor gene,
indicated that PTB stimulates cleavage/polyadenylation of
the transcript at the end of exon 4, which in turn forces the
selection of the non-neural splicing pattern [13]. It is
unclear at present whether PTB has a direct role in pro-
moting 3′ end formation or whether this effect is indirectly
caused by inhibiting the assembly of splicing factors close
to the sites of cleavage/polyadenylation. In any case, repres-
sive effects on splicing or activating effects on polyadenyla-
tion have the same consequence: to promote non-neural
patterns of gene expression.
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An additional ability of PTB was unexpectedly revealed by
studies of picornaviruses. The genomic RNA of these
viruses is translated from internal ribosome entry sites
(IRES) by mechanisms distinct from those governing the
cap-dependent initiation of translation of most eukaryotic
mRNAs. In vitro translation studies suggested that the effi-
cient use of IRES requires cellular components in addition
to canonical translation initiation factors. In a search for these
factors, PTB was found associated with many picornavirus
IRES [14], and depletion/reconstitution experiments
demonstrated that PTB stimulates translation initiated from
at least two of them [15,16]. The mechanisms used by PTB
to enhance IRES-dependent translation are presently
unknown. Although a role for PTB in the translation of cel-
lular mRNAs remains to be demonstrated, the presence of
IRES and PTB-binding sites in the 5′ untranslated region of
a variety of cellular mRNAs suggests that the observations
made in viruses may be revealing a more widespread —
albeit specific — mechanism of translational control.
The results that we have discussed hold the promise of
exciting developments in PTB research in the near future
and pose two general questions. The first general ques-
tion is whether the multiple activities of PTB have a
common mechanistic basis. Does PTB, for example,
induce conformational changes in RNA that occlude or
reveal structural features of the transcript which need to
be recognized by the machineries of RNA processing and
translation? The second general question is how does
PTB regulate posttranscriptional processing in a tissue-
specific and physiologically meaningful fashion? 
For PTB to be a physiologically important regulator, there
must be a way, or ways, of varying its activity in different
cell types. One simple way of achieving this would involve
cell-type-specific variation in the concentration of PTB, rel-
ative to other splicing, polyadenylation or translation factors.
Indeed, tissue-specific and cell-line-specific differences in
PTB levels have been reported [10,12,17]. A general
correlation between PTB abundance — or PTB activity,
possibly modulated by post-translational modifications —
and the choice of processing patterns has not yet been
made. An alternative possibility involves the presence of
tissue-specific PTB variants. In support of this idea, alterna-
tive RNA splicing generates at least four different PTB iso-
forms [2,17,18], and a brain-specific protein that reacts with
antibodies against PTB has recently been identified [10]. A
third way that PTB activity might be regulated is by differ-
ential association with other molecules. Proteins such as the
PTB-associated splicing factor (PSF), an essential splicing
factor that interacts with PTB [19], might associate with
PTB only in particular circumstances [12], and significantly
change the effect of PTB interaction with a cognate site.
These mechanisms are likely to be the focus of future work
that will show whether the dawn of PTB as a regulator of
gene expression turns into a sunny day.
Figure 2
Proposed activities of PTB in the alternative
splicing of c-src, γ2 GABAA receptor and
calcitonin/CGRP pre-mRNAs. Schemes and
symbols are as in Figure 1.
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